Gemina Laboratories Ltd.: Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited

VANCOUVER, BC / ACCESSWIRE / December 7, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that the Company has entered into a definitive share exchange

Related Keywords

United States ,Inverness ,Highland ,United Kingdom ,Canada ,Vancouver ,British Columbia ,Canadian ,John Davies ,Mike Catt ,Robert Porter ,Rob Porter ,Brian Firth ,National Instrument ,Company Prospectus ,Company Or Gemina ,Gemina Laboratories Ltd View ,United Kingdom National Physics Laboratory ,United Kingdom Department ,Unilever ,Rapivd Limited Rapiv ,Company Gemina ,Gemina Laboratories Ltd ,Gemina Laboratories ,Definitive Agreement ,Prospectus Supplement ,Antigen Test ,Gemina Advisory Board ,Professor Mike Catt ,Senior Scientific Director ,Inverness Medical ,National Physics Laboratory ,Argento Diagnostics ,Social Care ,Disclosure Obligations ,Option Exercise Period ,Gemina Shares ,Statements Regarding Forward Looking Information ,Eastern Europe ,United States Securities Act ,Gemina ,Laboratories ,Labs ,Nnounces ,Strategic ,Stake ,British ,Rapid ,Pest ,Eoptimizer ,Apivd ,Imited ,